Skin Microbiota – A Novel Target for Promoting Burn Wound Healing

Review article discussing
the wound microbiome and Amicapsil

Treatment of venous leg ulcers with Amicapsil

“Amicapsil healed my venous leg ulcers and changed my life.”

“From 4 weeks of absolute hell – to being pain-free, getting a full night’s sleep and back to normal at work.”

“From 4 weeks of absolute hell, in pain 24 hours a day, struggling at work – to being pain-free, getting a full night’s sleep and back to normal at work.”

NH ( patient)

SertaSil for veterinary wound treatment

SertaSil for veterinary wound care

Effective in treating severe infections, including infections not responding to antibiotics and antiseptics.

Treatment of wounds and pressure ulcers in persons with spinal cord injury

Amicapsil-SCI

Effective treatment of wounds and pressure ulcers in SCI-persons and in controlling soft tissue infection caused by osteomyelitis.

Pyoderma gangrenosum

Pyoderma gangrenosum (PG) is a rare neutrophilic inflammatory condition. It is characterised by painful, rapidly expanding, violaceous, undermined ulcers. Immunosuppressants are key to management, but large chronic ulcers often result.

University Hospital Birmingham, UK, evaluated MPPT in three patients with chronic inactive stable PG ulcers. The patients were treated with MPPT for five consecutive days. All demonstrated new granulation tissue consistent with improved healing. See the poster presented at the British Dermatology Association meeting in Edinburgh, July 2-5, 2018.

Pyoderma gangrenosum

Amicapsil and Amicapsil-SCI on NHS Supply Chain

July 15’th, 2025 – New analysis published in Frontiers in Public Health questions whether antimicrobials play a major role in causing climate change.

June 20’th, 2024 – Patient survey of MPPT published in Frontiers in Rehabilitation Sciences

January 5’th, 2024 – MPPT clinical study published in Frontiers in Medicine